An innovative hematopoietic stem cell gene therapy approach benefits CLN1 disease in the mouse model.
Peviani M, Das S, Patel J, Jno-Charles O, Kumar R, Zguro A, Mathews TD, Cabras P, Milazzo R, Cavalca E, et al. EMBO Mol Med. 2023 Apr 11; 15(4):e15968. Epub 2023 Mar 6.